Catalysts for $NVS
563 tracked
Jul 16, 2019
approval
TAFINLAR (DABRAFENIB MESYLATE) — FDA approval
dabrafenib mesylate ODT
→
Jul 16, 2019
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Jan 4, 2019
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Jan 4, 2019
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Aug 21, 2018
approval
GLEEVEC (IMATINIB MESYLATE) — FDA approval
Imatinib Mesylate Shilpa
→
Jun 19, 2018
approval
COSENTYX (SECUKINUMAB) — FDA approval
NOVARTIS AG
→
May 4, 2018
approval
TAFINLAR (DABRAFENIB MESYLATE) — FDA approval
dabrafenib mesylate ODT
→
May 4, 2018
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Apr 30, 2018
approval
TAFINLAR (DABRAFENIB MESYLATE) — FDA approval
dabrafenib mesylate ODT
→
Apr 30, 2018
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Apr 20, 2018
approval
TAFINLAR (DABRAFENIB MESYLATE) — FDA approval
dabrafenib mesylate ODT
→
Mar 22, 2018
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Mar 22, 2018
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Mar 20, 2018
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 20, 2018
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 20, 2018
approval
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 9, 2018
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Jan 23, 2018
approval
COSENTYX (SECUKINUMAB) — FDA approval
NOVARTIS AG
→
Nov 17, 2017
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Nov 17, 2017
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Oct 27, 2017
approval
ZOLEDRONIC ACID — FDA approval
NOVARTIS AG
→
Sep 29, 2017
approval
GLEEVEC (IMATINIB MESYLATE) — FDA approval
Imatinib Mesylate Shilpa
→
Sep 15, 2017
approval
COSENTYX (SECUKINUMAB) — FDA approval
NOVARTIS AG
→
Sep 6, 2017
approval
GLEEVEC (IMATINIB MESYLATE) — FDA approval
Imatinib Mesylate Shilpa
→
Jun 22, 2017
approval
TAFINLAR (DABRAFENIB MESYLATE) — FDA approval
dabrafenib mesylate ODT
→
Jun 22, 2017
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Jun 16, 2017
approval
TAFINLAR (DABRAFENIB MESYLATE) — FDA approval
dabrafenib mesylate ODT
→
Apr 24, 2017
approval
GLEEVEC (IMATINIB MESYLATE) — FDA approval
Imatinib Mesylate Shilpa
→
Mar 23, 2017
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Mar 23, 2017
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→